Cargando…
Molecular mechanisms underlying hyperglycemia associated cognitive decline
Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia. DM can lead to a number of secondary complications affecting multiple organs in the body including the eyes, kidney, heart, and brain. The most common effect of hyperglycemia on the brain is cognitive decline. It h...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800261/ https://www.ncbi.nlm.nih.gov/pubmed/36590246 http://dx.doi.org/10.1016/j.ibneur.2022.12.006 |
_version_ | 1784861257600335872 |
---|---|
author | Gupta, Mrinal Pandey, Shivani Rumman, Mohammad Singh, Babita Mahdi, Abbas Ali |
author_facet | Gupta, Mrinal Pandey, Shivani Rumman, Mohammad Singh, Babita Mahdi, Abbas Ali |
author_sort | Gupta, Mrinal |
collection | PubMed |
description | Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia. DM can lead to a number of secondary complications affecting multiple organs in the body including the eyes, kidney, heart, and brain. The most common effect of hyperglycemia on the brain is cognitive decline. It has been estimated that 20–70% of people with DM have cognitive deficits. High blood sugar affects key brain areas involved in learning, memory, and spatial navigation, and the structural complexity of the brain has made it prone to a variety of pathological disorders, including T2DM. Studies have reported that cognitive decline can occur in people with diabetes, which could go undetected for several years. Moreover, studies on brain imaging suggest extensive effects on different brain regions in patients with T2D. It remains unclear whether diabetes-associated cognitive decline is a consequence of hyperglycemia or a complication that co-occurs with T2D. The exact mechanism underlying cognitive impairment in diabetes is complex; however, impaired glucose metabolism and abnormal insulin function are thought to play important roles. In this review, we have tried to summarize the effect of hyperglycemia on the brain structure and functions, along with the potential mechanisms underlying T2DM-associated cognitive decline. |
format | Online Article Text |
id | pubmed-9800261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98002612022-12-31 Molecular mechanisms underlying hyperglycemia associated cognitive decline Gupta, Mrinal Pandey, Shivani Rumman, Mohammad Singh, Babita Mahdi, Abbas Ali IBRO Neurosci Rep Review Article Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia. DM can lead to a number of secondary complications affecting multiple organs in the body including the eyes, kidney, heart, and brain. The most common effect of hyperglycemia on the brain is cognitive decline. It has been estimated that 20–70% of people with DM have cognitive deficits. High blood sugar affects key brain areas involved in learning, memory, and spatial navigation, and the structural complexity of the brain has made it prone to a variety of pathological disorders, including T2DM. Studies have reported that cognitive decline can occur in people with diabetes, which could go undetected for several years. Moreover, studies on brain imaging suggest extensive effects on different brain regions in patients with T2D. It remains unclear whether diabetes-associated cognitive decline is a consequence of hyperglycemia or a complication that co-occurs with T2D. The exact mechanism underlying cognitive impairment in diabetes is complex; however, impaired glucose metabolism and abnormal insulin function are thought to play important roles. In this review, we have tried to summarize the effect of hyperglycemia on the brain structure and functions, along with the potential mechanisms underlying T2DM-associated cognitive decline. Elsevier 2022-12-13 /pmc/articles/PMC9800261/ /pubmed/36590246 http://dx.doi.org/10.1016/j.ibneur.2022.12.006 Text en © 2022 Published by Elsevier Ltd on behalf of International Brain Research Organization. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Gupta, Mrinal Pandey, Shivani Rumman, Mohammad Singh, Babita Mahdi, Abbas Ali Molecular mechanisms underlying hyperglycemia associated cognitive decline |
title | Molecular mechanisms underlying hyperglycemia associated cognitive decline |
title_full | Molecular mechanisms underlying hyperglycemia associated cognitive decline |
title_fullStr | Molecular mechanisms underlying hyperglycemia associated cognitive decline |
title_full_unstemmed | Molecular mechanisms underlying hyperglycemia associated cognitive decline |
title_short | Molecular mechanisms underlying hyperglycemia associated cognitive decline |
title_sort | molecular mechanisms underlying hyperglycemia associated cognitive decline |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800261/ https://www.ncbi.nlm.nih.gov/pubmed/36590246 http://dx.doi.org/10.1016/j.ibneur.2022.12.006 |
work_keys_str_mv | AT guptamrinal molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline AT pandeyshivani molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline AT rummanmohammad molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline AT singhbabita molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline AT mahdiabbasali molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline |